4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002110
Chief Discovery/Trans Medicine sold 10,338 shares at an average $38.38 ($396,738)
- Chief Discovery/Trans Medicine acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Hamilton James C · Chief Discovery/Trans Medicine
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Sale : show line 1 in the form | −1,194 | $37.46 | $44,727 | 154,431 | D |
| 2023-01-03 | Sale : show line 2 in the form | −2,837 | $38.53 | $109,310 | 151,594 | D |
| 2023-01-03 | Sale : show line 3 in the form | −300 | $39.74 | $11,922 | 151,294 | D |
| 2023-01-03 | Sale : show line 4 in the form | −136 | $40.54 | $5,513 | 151,158 | D |
| 2023-01-03 | Sale : show line 5 in the form | −1,642 | $37.49 | $61,559 | 149,516 | D |
| 2023-01-03 | Sale : show line 6 in the form | −3,682 | $38.52 | $141,831 | 145,834 | D |
| 2023-01-03 | Sale : show line 7 in the form | −300 | $39.56 | $11,868 | 145,534 | D |
| 2023-01-03 | Sale : show line 8 in the form | −247 | $40.52 | $10,008 | 145,287 | D |
| 2023-01-04 | Grant or award : show line 9 in the form | +60,000 | 205,287 | D | ||
| Open-market sales · 10,338 sh · avg $38.38 · $396,738 | ||||||
Loading xslF345X03/doc4.xml…